Brief: Mink Therapeutics Reports Quarterly Loss Per Share Of $0.19
03/11/2022 12:47
Nov 3 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS REPORTS CORPORATE UPDATE AND THIRD
QUARTER
2022 FINANCIAL RESULTS
* QTRLY LOSS PER SHARE $0.19
Source text for Eikon: ID:nGNXc2zM6h
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's